Strategy

Pharmacy deserts, areas where the nearest pharmacy is over 15 minutes away, are a reality for between 15 million to 41 million Americans, representing over 40% of counties in the US. This lack of access to essential medications and pharmaceutical services can have serious implications for health outcomes. The pandemic also altered consumers’ expectations for how they receive healthcare, shifting significant portions of the healthcare experience into the digital world, and placing an even greater burden on the pharmacy network to make medications accessible. Emerging technology can fortunately play a significant role in bridging this gap.

In a world where commerce has evolved to prioritize customer experience, the patient experience in the pharmaceutical industry lags significantly behind. Ease of shopping, price transparency, and personalized options have become the expected experience for consumers. Yet the patient journey for prescription drugs remains fractured and devoid of these crucial elements.

Hospital readmission rates expose both a devastating outcome for patients and a major cost driver for the American healthcare system. According to the Nationwide Readmissions Database, the overall 30-day readmission rate hovers around 14 percent, costing the United States an estimated $41.3 billion each year.With advancements in digital healthcare, technology must play a bigger role in reducing Potentially Preventable Readmissions. 

Our mission is to revolutionize the way businesses and institutions build next-gen solutions that allow patients to receive best-in-class healthcare, making it easier and more convenient than ever before. We're excited about the future and can't wait to see what the coming years will bring.

As Hollywood heads back into production, some are finding prohibitive costs for ensuring Covid-19 safety.

“Covid-19 testing is on the decline. That’s a problem.” That’s the headline from a recent article published by the New York Times describing the urgent situation we find ourselves in one year later ...

For companies who are facing the question of how to reopen safely & securely, but are also worried about the costs of implementing a new corporate testing program, the answer is clear: “It pays for itself."

For companies that are considering launching or overhauling an existing corporate testing program, what are the three most important considerations to keep front of mind when building your program?

Businesses are faced with a lot of opinions, voices, and theories about the ideal approach for ensuring a safe return to the office. Even with the best intentions, organizations run the risk of missing the broader social context that can help them make the decision that is best for employee equity and engagement.

Engaged employees perform better. They’re happier, they’re more productive, they stay with organizations longer, and yes, they’re even healthier than their less engaged counterparts. And while COVID-19 has strained businesses and employees alike, providing comprehensive testing as offices reopen offers an incredible opportunity for companies to improve employee engagement across the board.

With the CDC updating its guidelines around mask-wearing for fully vaccinated Americans, many states have dropped their mask mandates. For some, this heralds a long overdue return to normalcy. For others, losing a proven -- and visible -- means of protection is a source of anxiety. Irrespective of how individuals feel about these changes, however, one thing is certain: lifting mask mandates makes fast, reliable testing more critical than ever.

This fall, colleges across the US will be welcoming students back to campus for the first time in a post-vaccine world. And while many schools are adopting some form of vaccination requirements for new and returning students, these policies remain fragmented, often confusing, and challenging to enforce. Against this backdrop, it’s vitally important for colleges to supplement their vaccine requirements with robust on-demand testing -- and they need to move fast in the process.

It can be strange to think about a world in which we live alongside COVID-19. What things will return to normal? Which will have to change, and to what extent? To better understand the issue, it’s helpful to explore what endemic COVID-19 may look like and what potential risks there might be going forward. 

COVID-19 burned through America’s correctional and detention facilities over the past year. According to The New York Times, 1 in 3 inmates in state facilities have contracted the disease, as have at least 39% of federal prisoners. Combined with the fact that COVID-19-related death rates are 34% higher among inmates than in the general population, these numbers illustrate the dire nature of this ongoing crisis.

More than a year after the first quarantines, cruise ships have once again started sailing out of North America. While this is a welcome relief for vacationers eager to get out into the world after months of lockdown, recent cruise-related COVID-19 incidents highlight both the risks that still exist and the important role testing plays in mitigating them.

The story of reopening cruise lines is much larger than originally believed. Today, we’re looking at three more aspects of the cruise industry’s return that can help us better understand the challenges that all industries are likely to face going forward.

The burst of shopping that followed the initial pandemic economic contractions has skyrocketed demand for foreign goods. With this fevered pace of shipping and receiving comes a much greater risk for exposure to and the spreading of COVID-19 and its variants. What can be done? Diligent testing.

Many companies and event organizations are ready to get back together. Here are 4 tips on safely hosting corporate events again.